Dr. Harindu Wijesinghe is a medical specialist in Rheumatology and Rehabilitation, as well as in Sports Medicine. He ...

A landmark global modeling study reveals that more than 2.8 billion people in 104 countries are at risk of chikungunya, with ...

France confirms its first locally transmitted chikungunya case of 2025 in La Crau, Var, as health officials ramp up mosquito control efforts.

Paris: Health authorities in France have confirmed the first locally transmitted case of mosquito-borne chikungunya this year ...

Climate change is reshaping Europe’s disease landscape, with tropical mosquito-borne illnesses like dengue and chikungunya ...

Health authorities in France have confirmed the first locally transmitted case of mosquito-borne chikungunya this year.The R ...

Use precise geolocation data and actively scan device characteristics for identification. This is done to store and access ...

Results from the Phase II VLA1553-221 trial show that a full dose of Ixchiq demonstrated a 96.5% seroresponse rate in ...

COPENHAGEN, Denmark, June 12, 2025 – Bavarian Nordic A/S (OMX: BAVA) announced today the initiation of a Phase 3 clinical study of its single-dose, virus-like particle (VLP) chikungunya vaccine, CHIKV ...

Valneva reports positive six-month data for Ixchiq in children, supporting a full dose approach ahead of a Phase 3 trial set ...

The UK’s Medicines and Healthcare products Regulatory Agency said that following global reports of serious adverse events in ...

UK's medicine regulator said on Monday it has temporarily restricted the use of French vaccine maker Valneva's shot to treat ...